Article content continued

Wana Lozenges will also be available, containing 5mg THC each to enable effective and precise dosing.

This agreement solidifies Wana Brands continued expansion from its Colorado headquarters, where it is the No. 1 infused products cannabis brand, according to BDS Analytics’ May 2018 Brandshare Report. The company’s popular products are also available in Arizona, Oregon and Nevada dispensaries, with Illinois among the states imminently coming online.

Wana Brands expects to expand into California, Maryland, Michigan, Ohio, Pennsylvania, Washington, and internationally in Canada through 2019.

“With our products such as WanaCaps XR , Wana Brands is perfectly positioned to provide reliable and consistent products to Florida’s medical marijuana patients,” said Nancy Whiteman, Founder, and CEO of Wana Brands. “Wana Brands has developed a remarkable line-up of cannabis products that have been built on precision, quality, professionalism, and innovation. We have invested in refining our recipes for patients, so that the taste of our products comes through, not the taste of medicine. We look forward to introducing our lozenges and extended-release capsules to the Florida market as well.”

“As a national brand and an award-winning customer favorite, Wana Brands is known for its consistent quality and rounds out the portfolio of products offered to our patients,” said John Tipton, CEO of AltMed Florida.

Florida’s medical cannabis market is expected to grow rapidly and exceed $1 billion by 2020. With a population of 21 million, 19 percent of whom are seniors, Florida is estimated to eventually have hundreds of thousands of medical marijuana patients. The burgeoning system currently has 138,558 registered patients and 1,572 registered physicians, with 400,000 patients forecast by 2020.